All-Trans Retinoic Acid Synergizes with Enasidenib to Induce Differentiation of IDH2-Mutant Acute Myeloid Leukemia Cells
Open Access
- 1 January 2020
- journal article
- research article
- Published by XMLink in Yonsei Medical Journal
- Vol. 61 (9) , 762-773
Abstract
Kim Y, et al. Yonsei Med J. 2020 Sep;61(9):762-773. https://doi.org/10.3349/ymj.2020.61.9.762Keywords
Funding Information
- National Research Foundation of Korea (2017R1D1A1B03036419)
This publication has 37 references indexed in Scilit:
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid LeukemiaNew England Journal of Medicine, 2013
- Acute myeloid leukemia in the real world: why population-based registries are neededBlood, 2012
- IDH mutation impairs histone demethylation and results in a block to cell differentiationNature, 2012
- Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndromeNature Genetics, 2011
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent DioxygenasesCancer Cell, 2011
- Autophagy in mammalian development and differentiationNature Cell Biology, 2010
- Effect of Complete Remission and Responses Less Than Complete Remission on Survival in Acute Myeloid Leukemia: A Combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center StudyJournal of Clinical Oncology, 2010
- Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutationsJournal of Experimental Medicine, 2010
- Methods in Mammalian Autophagy ResearchCell, 2010
- An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience, 2008